HBV Mutation Detail Information

> G1896A Search Result


Mutation Information
Mutation Site G1896A
Mutation Type Nucleotide level
Gene/Protein/Region Type PreC
Nucleotide_Mutation W28*
Genotype/Subtype A;D;F
Relevant Drug lamivudine (LAM)
Country Korea
Literature Information
PubMed PMID 15932365
Disease Chronic hepatitis B
Published Year 2005
Journal Alimentary pharmacology & therapeutics
Title Changes in different regions of hepatitis B virus gene in hepatitis B 'e' antigen-negative patients with chronic hepatitis B: the effect of long-term lamivudine therapy.
Author Buti M,Jardi R,Rodriguez-Frias F,Valdes A,Schaper M,Esteban R,Guardia J
Evidence Analysis of HBV precore mutation G1896A in the serum samples obtained before treatment and during the 5 years of treatment (relationship between therapy response and HBV genotypes)

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation